Edgewell Personal Care Reports Modest Sales Growth but Significant Profit Decline in Q3 2026

Edgewell Personal Care Company reported its financial results for the third quarter and nine months ended June 30, 2026, revealing a modest increase in net sales but a significant decline in profitability compared to the previous fiscal period. For the third quarter, net sales reached $570.1 million, up 1.7% from $560.4 million in the same quarter last year. The increase was attributed to a 3.0% rise in North American sales, driven by volume growth in Sun and Skin Care products, although this was partially offset by a decline in international sales due to supply chain disruptions. For the nine months, net sales totaled $1.512 billion, a 1.4% increase from $1.492 billion in the prior year.

Despite the increase in sales, Edgewell's profitability took a hit. The company reported net earnings from continuing operations of $12.3 million for the third quarter, down from $21.5 million a year earlier. For the nine months, the company experienced a net loss of $12.9 million, compared to a profit of $32.1 million in the same period last year. The decline in earnings was primarily due to lower gross margins and higher operating expenses, which included increased selling, general, and administrative costs as well as restructuring charges related to operational consolidations.

Strategically, Edgewell completed the divestiture of its Feminine Care segment to Essity for approximately $340 million in February 2026, a move aimed at refocusing the company on its core personal care products. The results from the Feminine Care segment are now classified as discontinued operations. The company has also been consolidating its Wet Shave operations and facilities in Mexico to improve efficiency, which is expected to incur additional restructuring costs.

Operationally, Edgewell's total assets decreased to $3.535 billion as of June 30, 2026, down from $3.756 billion at the end of the previous fiscal year. The company reported cash and cash equivalents of $397.1 million, significantly up from $225.7 million, largely due to the proceeds from the Feminine Care sale. The company’s employee headcount remained stable, and it continues to focus on enhancing its product offerings and market share in the personal care sector.

Looking ahead, Edgewell anticipates continued challenges in the market, particularly related to inflationary pressures and supply chain disruptions. The company is focused on leveraging its cash reserves and operational efficiencies to navigate these challenges while investing in growth initiatives. The outlook remains cautious, with expectations for ongoing adjustments in response to market conditions and consumer demand.